ArticleAlzheimer's research & therapy2019

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau.

Matthias Brendel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.